文献速递甲状腺与颈部外科围术期管理与 ERAS

透析患者继发性甲旁亢:甲状旁腺次全切除与全切除加自体移植的短期和长期结局比较

Subtotal Parathyroidectomy vs Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Dialysis Patients: Short- and Long-Term Outcomes.
PubMed 文献 · J Am Coll Surg · 2019-02-15

本研究回顾性比较46例透析继发性甲旁亢患者接受甲状旁腺次全切除(SPTX)与全切除加自体移植(TPTX-AT)的结局。TPTX-AT长期控制甲状旁腺激素升高及避免复发更优,但术后长期低钙血症风险更高;SPTX则长期PTH>200 pg/mL比例更高。

要点

  • TPTX-AT长期PTH>200 pg/mL比例低于SPTX(6.7% vs 38.9%,p≤0.05)。
  • TPTX-AT长期补钙超过6个月比例高于SPTX(71.4% vs 36.8%,p<0.05)。
  • 两种术式再手术率、出院钙剂剂量及住院时间无显著差异。

核心结论

  • TPTX-AT对长期PTH升高的控制及避免复发优于SPTX,但长期低钙血症风险更高。

研究设计与样本

  • 回顾性综述,纳入2006至2017年一家719张床三级医院46例接受PTX的透析继发性甲旁亢患者。

主要发现

  • 术后第1天钙:SPTX 7.7±0.8 mg/dL,TPTX-AT 7.9±1.3 mg/dL(p=0.49)。
  • 术后第1天PTH:SPTX 32.6±26.0 pg/mL,TPTX-AT 9.5±4.2 pg/mL(p≤0.05)。
  • 住院时间:SPTX 3.7±1.9天,TPTX-AT 4.4±3.5天(p=0.46)。
  • 复发或持续疾病再手术:SPTX 6例,TPTX-AT 2例(p=0.12)。
  • 长期随访PTH<15 pg/mL:SPTX 5.6%,TPTX-AT 26.7%(p=0.09)。

临床怎么用

  • 对复发风险高、能密切监测血钙的透析患者可优先考虑TPTX-AT。
  • 选择SPTX时需关注长期PTH升高及复发风险。
  • TPTX-AT术后需加强长期钙剂和骨化三醇补充管理。

局限性

  • 回顾性单中心设计,样本量46例,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two operations are performed for management of secondary hyperparathyroidism, subtotal parathyroidectomy (SPTX) and total parathyroidectomy with autotransplantation (TPTX-AT). There is no consensus among endocrine surgeons about which operation is the preferred treatment. This study compares the short- and long-term outcomes of SPTX and TPTX-AT for dialysis patients with secondary hyperparathyroidism. STUDY DESIGN: This is a retrospective review of 46 dialysis patients undergoing PTX from 2006 to 2017 at a 719-bed tertiary care hospital. RESULTS: Calcium on postoperative day 1 was 7.7 ± 0.8 mg/dL for SPTX and 7.9 ± 1.3 mg/dL for TPTX-AT (p = 0.49). Parathyroid hormone values on postoperative day 1 were 32.6 ± 26.0 pg/mL for SPTX and 9.5 ± 4.2 pg/mL for TPTX-AT (p ≤ 0.05). Hospital length of stay was 3.7 ± 1.9 days for SPTX and 4.4 ± 3.5 days for TPTX-AT (p = 0.46). The required doses of calcium and calcitriol at discharge did not differ significantly. Reoperation for recurrence or persistence of disease was required in 6 SPTX patients and 2 TPTX-AT patients (p = 0.12). Parathyroid hormone values <15 pg/mL at long-term follow-up occurred in 5.6% of SPTX patients and 26.7% of TPTX-AT patients (p = 0.09). Parathyroid hormone values >200 pg/mL at long-term follow-up occurred in 38.9% of SPTX patients vs 6.7% of the TPTX-AT patients (p ≤ 0.05). Calcium supplementation at more than 6 months was required for 36.8% of SPTX and 71.4% of TPTX-AT patients (p < 0.05). CONCLUSIONS: The long-term control of parathyroid hormone elevation and avoidance of recurrent disease is improved with TPTX-AT, but carries a higher risk of long-term hypocalcemia.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Zmijewski PV, Staloff JA, Wozniak MJ, et al. Subtotal Parathyroidectomy vs Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Dialysis Patients: Short- and Long-Term Outcomes. J Am Coll Surg. 2019. PMID: 30776511. doi:10.1016/j.jamcollsurg.2019.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。